Suchergebnisse - "Janjigian, Yelena Y"

PubPharm (209)

31

Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma

enthalten in: JAMA network open | 2022

von Tsai, C. | Nguyen, B. | Luthra, A. | +17

32

Should chemoradiotherapy be standard to maximise cure in localised gastro-oesophageal cancer?

enthalten in: The Lancet. Oncology | 2022

von Reynolds, J. | Cowzer, D. | Janjigian, Y.

33

MATTERHORN : phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer

enthalten in: Future oncology (London, England) | 2022

von Janjigian, Y. | Van Cutsem, E. | Muro, K. | +9

34

The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Sihag, S. | Nussenzweig, S. | Walch, H. | +15

35

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

enthalten in: bioRxiv.org | 2022

von Nguyen, B. | Fong, C. | Luthra, A. | +71

36

Top advances in esophageal/gastroesophageal junction cancers in 2021

enthalten in: Cancer | 2022

von Cowzer, D. | Janjigian, Y.

37

ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas : Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications

enthalten in: Journal of the National Cancer Institute | 2022

von El Jabbour, T. | Misyura, M. | Cowzer, D. | +19

ErratumIn: J Natl Cancer Inst. 2023 Jun 8;115(6):770. - PMID 37178142

38

Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer

enthalten in: Nature communications | 2022

von Pereira, P. | Mandleywala, K. | Monette, S. | +10

39

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

enthalten in: Nature | 2022

von Shitara, K. | Ajani, J. | Moehler, M. | +26

40

Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma

enthalten in: Cancer chemotherapy and pharmacology | 2022

von Moy, R. | Greally, M. | Chou, J. | +9